课题基金 / 基金详情

A COMBINATION TRIAL OF COPAXONE PLUS ESTRIOL IN RELAPSING REMITTING MULTIPLE

A COMBINATION TRIAL OF COPAXONE PLUS ESTRIOL IN RELAPSING REMITTING MULTIPLE
科帕松加雌三醇治疗多发性复发缓解的联合试验
批准号：
8171164
负责人：
RHONDA R VOSKUHL
金额：
$0.61万
依托单位：
UNIVERSITY OF CALIFORNIA LOS ANGELES
依托单位国家：
美国
项目类别：
财政年份：
2010
资助国家：
美国
项目状态：
已结题
起止时间：
2010-08-01 至 2011-07-31
来源：
https://reporter.nih.gov/project-details/8171164
关键词：
Computer Retrieval of Information on Scientific Projects DatabaseCopaxoneDiseaseEstriolFundingGrantImageInstitutionMeasuresOralRelapseRelapsing-Remitting Multiple SclerosisResearchResearch PersonnelResourcesSourceUnited States National Institutes of HealthWomandouble-blind placebo controlled trial

项目摘要

项目成果

RHONDA R VOSKUHL的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 “科帕松联合雌三醇治疗复发性缓解性多发性硬化症” 一项多中心、双盲、安慰剂对照试验，通过复发率、影像和免疫学标记物的测量，确定口服雌三醇治疗在减少复发缓解性多发性硬化症妇女的疾病活动性方面是否有效。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. "A combination trial of copaxone plus estriol in relapsing remitting multiple sclerosis" A multicenter double blind placebo controlled trial to determine if oral estriol treatment is effective in decreasing disease activity in women with relapsing remitting multiple sclerosis as measured by relapse rate, imaging and immunological markers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neurodegeneration Underlying Distinct Disabilities in Multiple Sclerosis Using a Cell-Specific, Region-Specific, and Sex-Specific Approach
Neuroprotection in MS: A Cell-Specific and Region-Specific Transcriptomics Approach
Neuroprotection in MS: A Cell-Specific and Region-Specific Transcriptomics Approach
Neuroprotection in MS: A Cell-Specific and Region-Specific Transcriptomics Approach
海外基金